SHARE CAPITAL, WARRANTS AND OPTIONS | 7. SHARE CAPITAL, WARRANTS AND OPTIONS The authorized capital of the Company comprises an unlimited number of common shares without par value and 100,000,000 a) Common shares issued and outstanding 2022 During the three months period ended March 31, 2022, the Company issued 2,665,404 379,563 2,665,404 6,278,219 665,135 6,278,219 As at March 31, 2022, the Company has 133,870,031 116,111,867 Notes to the unaudited Condensed Interim Consolidated Financial Statements For the three months ended March 31, 2022 (Expressed in Canadian dollars) 2021 During the year ended December 31, 2021, the Company issued 13,080,314 1,641,675 12,580,314 112,000 500,000 no As at December 31, 2021, the Company has 131,204,627 109,833,648 On April 20, 2021 the Company closed a non-brokered private placement consisting of an aggregate of 8,290,665 0.24 1,989,760 Each unit consists of one common share in the capital of the Company and one half transferable common share purchase warrant (“Warrant”) of the Company. Each full Warrant entitles the holder to acquire one common share of the Company within twenty-four (24) months following its issuance date, at a price of $0.35. The warrants are subject to an acceleration clause such that if the closing market price of the common shares on the TSX-V is greater than $0.60 per common share for a period of 10 consecutive trading days at any time after the four-month anniversary of the closing of the placement, the Company may, at its option, accelerate the warrant expiry date to within 30 days. In connection with the private placement, the Company has paid eligible finders (the “Finders”): (i) cash commission equal to 6% of the gross proceeds raised from subscribers introduced to the Company by such Finders, being an aggregate of $65,830, and (ii) a number of common share purchase warrants (the “Finder Warrants”) equal to 6% of the units attributable to the Finders under the private placement, being an aggregate of 274,289 Finder Warrants. Each Finder Warrant entitles the Finder to acquire one common share of the Company for a period of twenty-four (24) months following its issuance date, at an exercise price of $0.35. The Company allocated a $ 464,493 30,735 1.5 0 0.29 132 b) Preferred shares issued and outstanding As at March 31, 2022 and March 31, 2021 there are 590,931 The rights and restrictions of the preferred shares are as follows: i) dividends shall be paid at the discretion of the directors; ii) the holders of the preferred shares are not entitled to vote except at meetings of the holders of the preferred shares, where they are entitled to one vote for each preferred share held; iii) the shares are convertible at any time after 6 months from the date of issuance, upon the holder serving the Company with 10 days written notice; and iv) the number of the common shares to be received on conversion of the preferred shares is to be determined by dividing the conversion value of the share, $1 per share, by $ 9.00 Notes to the unaudited Condensed Interim Consolidated Financial Statements For the three months ended March 31, 2022 (Expressed in Canadian dollars) c) Warrants A summary of common share purchase warrants activity during the three months period ended March 31, 2022 is as follows: SCHEDULE OF NUMBER AND WEIGHTED AVERAGE EXERCISE PRICES OF WARRANTS March 31, 2022 December 31, 2021 Number Outstanding Weighted Average Exercise Price ($) Number Outstanding Weighted Average Exercise Price ($) Outstanding, beginning of year 16,082,825 0.15 25,715,742 0.11 Issued - - 4,419,620 0.35 Exercised (2,665,404 ) 0.14 (12,580,314 ) 0.13 Cancelled / expired - - (1,472,223 ) 0.25 Outstanding, end of year 13,417,421 0.16 16,082,825 0.15 At March 31, 2022, the Company had outstanding common share purchase warrants exercisable to acquire common shares of the Company as follows: SCHEDULE OF NUMBER AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OUTSTANDING WARRANTS Warrants Outstanding Expiry Date Exercise Price ($) Weighted Average remaining contractual life (years) 8,871,817 1 August 13, 2022 0.09 0.24 1,076,067 1 August 31, 2022 0.09 0.03 3,469,537 April 16, 2023 0.35 0.26 13,417,421 0.53 1 The warrants are subject to an acceleration clause such that if the volume-weighted average trading price of the Company’s common shares on the TSX-V exceeds $ 0.12 10 The average share price at the dates the finders’ warrants were exercised was $ 0.34 (d) Stock options The Company adopted a Stock Option Plan (the “Plan”), providing the authority to grant options to directors, officers, employees and consultants enabling them to acquire up to 10 10 A summary of option activity under the Plan during the three months period ended March 31, 2022 is as follows: SCHEDULE OF NUMBER AND WEIGHTED AVERAGE EXERCISE PRICES OF SHARE OPTIONS March 31, 2022 December 31, 2021 Number Outstanding Weighted Average Exercise Price ($) Number Outstanding Weighted Average Exercise Price ($) Outstanding, beginning of year 15,054,597 0.27 7,978,725 0.17 Issued - - 8,178,972 0.37 Exercised - - (500,000 ) 0.22 Cancelled / expired (75,625 ) 1.20 (603,100 ) 0.31 Outstanding, end of year 14,978,972 0.27 15,054,597 0.27 Notes to the unaudited Condensed Interim Consolidated Financial Statements For the three months ended March 31, 2022 (Expressed in Canadian dollars) There were no During the three months period ended March 31, 2021, the Company granted an aggregate total of 3,185,000 5 0.32 837,444 During the year ended December 31, 2021, the Company granted an aggregate total of 8,178,972 5 3,185,000 0.32 4,993,972 0.40 2,530,706 0.31 The fair value of stock options granted and vested during the periods ended March 31, 2022 and 2021 was calculated using the following assumptions: SCHEDULE OF INPUTS TO OPTION PRICING MODEL March 31, 2022 March 31, 2021 Expected dividend yield - 0 % Expected share price volatility - 127.83 % Risk free interest rate - 0.93 % Expected life of options - 5 Details of options outstanding as at March 31, 2022 are as follows: SCHEDULE OF NUMBER AND WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OUTSTANDING SHARE OPTIONS Options Outstanding Options Exercisable Expiry Date Exercise Price ($) Weighted average remaining contractual life (years) 5,800,000 5,800,000 February 24, 2025 0.16 1.13 1,200,000 1,200,000 August 19, 2025 0.09 0.27 2,985,000 2,985,000 February 25, 2026 0.32 0.78 4,993,972 4,993,972 October 25, 2026 0.40 1.52 14,978,972 14,978,972 3.70 d) Reserve The reserve records items recognized as stock-based compensation expense and other share-based payments until such time that the stock options or warrants are exercised, at which time the corresponding amount will be transferred to share capital. Amounts recorded for forfeited or expired unexercised options and warrants are transferred to deficit. During the three months period ended March 31, 2022, the Company transferred $ 61,676 97,953 138,662 242,901 During the three months period ended March 31, 2022, the Company recorded $ Nil 837,444 Notes to the unaudited Condensed Interim Consolidated Financial Statements For the three months ended March 31, 2022 (Expressed in Canadian dollars) |